menu search

Investor alert: abbott cooper pllc announces investigation into zentalis pharmaceuticals, inc.; urges zentalis stockholders to contact abbott cooper regarding their legal rights

STAMFORD, Conn., Nov. 04, 2023 (GLOBE NEWSWIRE) — Abbott Cooper PLLC is investigating Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL) (“Zentalis” ...

November 4, 2023, 3:53 pm

Actinium pharmaceuticals: the trickle down continues, and i maintain a buy

Actinium pharmaceuticals continues to make progress with their radiolabelled CD45 antibody Iomab-B, whi...

November 3, 2023, 6:08 pm

Quoin pharmaceuticals announces third quarter 2023 financial results and corporate update conference call to be held on thursday november 9th at 8:30 am et

ASHBURN, Va., Nov. 03, 2023 (GLOBE NEWSWIRE) — Quoin pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Comp...

November 3, 2023, 12:41 pm

Quoin pharmaceuticals announces third quarter 2023 financial results and corporate update conference call to be held on thursday november 9th at 8:30 am et

ASHBURN, Va., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Quoin pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Compa...

November 3, 2023, 8:41 am

Acadia pharmaceuticals inc. (acad) q3 2023 earnings call transcript

ACADIA pharmaceuticals Inc. (NASDAQ:ACAD ) Q3 2023 Earnings Conference Call November 2, 2023 5:00 PM ET...

November 3, 2023, 3:54 am

Apellis alert: bragar eagel & squire, p.c. is investigating apellis pharmaceuticals, inc. on behalf of long-term stockholders and encourages investors to contact the firm

NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...

November 3, 2023, 1:00 am

Syndax pharmaceuticals inc (sndx) q3 2023 earnings call transcript

Syndax pharmaceuticals Inc (SNDX) Q3 2023 Earnings Call Transcript...

November 2, 2023, 9:26 pm

Ngm biopharmaceuticals (ngm) reports q3 loss, misses revenue estimates

NGM Biopharmaceuticals (NGM) came out with a quarterly loss of $0.35 per share versus the Zacks Consens...

November 2, 2023, 6:47 pm

Vertex pharmaceuticals (vrtx) rises higher than market: key facts

The latest trading day saw Vertex pharmaceuticals (VRTX) settling at $376.55, representing a +1.95% cha...

November 2, 2023, 6:47 pm

Ionis pharmaceuticals, inc. (ions) q3 2023 earnings call transcript

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS ) Q3 2023 Earnings Conference Call November 2, 2023 11:30 AM ET Company Participants Wade Walke - Senior Vice...

November 2, 2023, 5:20 pm

Aurinia pharmaceuticals inc. (auph) q3 2023 earnings call transcript

Aurinia pharmaceuticals Inc. (NASDAQ:AUPH ) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM E...

November 2, 2023, 12:06 pm

Gsk falls victim of ‘hard to please' pharma market

GSK PLC (LSE:GSK, NYSE:GSK)'s seemingly positive earnings release on Wednesday has been labelled as just that by Stifel analysts, who were left mullin...

November 2, 2023, 11:02 am

Corvus pharmaceuticals to present new interim soquelitinib data from its phase 1/1b t cell lymphoma trial at the 65th american society of hematology (ash) annual meeting & exposition

BURLINGAME, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today ...

November 2, 2023, 9:15 am

Agios pharmaceuticals to present broad set of clinical and translational data in rare blood disorders at 65th ash annual meeting and exposition

– Both Mitapivat Dose Arms Achieved Statistically Significant Hemoglobin Response in Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease...

November 2, 2023, 9:05 am

Aurinia pharmaceuticals (auph) reports q3 loss, tops revenue estimates

Aurinia pharmaceuticals (AUPH) came out with a quarterly loss of $0.09 per share versus the Zacks Conse...

November 2, 2023, 8:16 am

Novabay pharmaceuticals to hold third quarter 2023 conference call on november 9, 2023

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the thre...

November 2, 2023, 6:50 am

Regeneron pharma's adjusted earnings beat estimates

Regeneron pharmaceuticals Inc.'s stock REGN, +1.46% rose fractionally on Thursday after the drug maker ...

November 2, 2023, 6:49 am

Regeneron beats quarterly profit estimates on eczema treatment strength

Regeneron pharmaceuticals on Thursday beat Wall Street estimates for third-quarter profit, driven by st...

November 2, 2023, 6:42 am


Search within

Pages Search Results: